Stockchase Opinions

Colin Stewart Waterloo Brewing Ltd. WBR-T BUY Mar 17, 2021

Outlook is fantastic. Stock's done well. Very efficient manufacturing. Recent expansion. Has won contracts to produce and package for other companies, and there's room to grow. Well run, high insider ownership. Still good upside.
$6.200

Stock price when the opinion was issued

breweries beverages
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

COMMENT
Looking at the craft brewing market, it's very niche and we've seen big companies acquire smaller craft breweries. He expects the same thing happening for cannabis infused drinks. There's a strong seasonality to the stock, but it has stayed strong. Cannabis infused beverages could have big upsides for them.
PAST TOP PICK
(A Top Pick Nov 19/18, Down 6%) A craft brewing company that also receives outsourcing from bigger brewing companies. A house of brands type company. Strong management team that has grown revenue successfully. A small cap stock that isn’t well followed by investors. A potential takeover candidate.
TOP PICK
They have grown significantly over the last couple of years though craft brands as well as discount brands. The won a fair bit of business in contract brewing. He thinks the outlook is good. (Analysts’ price target is $7.25)
BUY ON WEAKNESS
Allan Tong’s Discover Picks WBR stock is a small-cap, so beware of volatility, trading only 22,000 shares per day. It pays a 1.49% dividend, far smaller than a few years ago. The big reason is that share prices have soared. In the past 12 months, WBR has run from $2.98 the way to $7.99 as of Monday’s close. It trades at 95x earnings, but remember that the industry average is 272x. The gross margin is slightly below its peers of 25.7%, but Waterloo’s profit margin is 3.46% vs. the industry’s -1.07%. Waterloo boasts the highest ROE in the industry at 8.88% compared to 3.23%. Read 3 Hot Canadian Summer Stocks for our full analysis.
BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Sales were 3% less than expected. EPS was better, at 4.8cents. Revenues grew 15% thanks to pandemic restrictions being eased. EBITDA rose 67%. A good recovery quarter. Ok buying this for small cap allocation. Unlock Premium - Try 5i Free